1-21563291-CGG-CG
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000478.6(ALPL):c.472+12delG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.153 in 1,607,190 control chromosomes in the GnomAD database, including 20,642 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000478.6 intron
Scores
Clinical Significance
Conservation
Publications
- adult hypophosphatasiaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet
- childhood hypophosphatasiaInheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, ClinGen, Orphanet
- hypophosphatasiaInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, G2P
- infantile hypophosphatasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia
- odontohypophosphatasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- perinatal lethal hypophosphatasiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ALPL | NM_000478.6 | c.472+12delG | intron_variant | Intron 5 of 11 | ENST00000374840.8 | NP_000469.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ALPL | ENST00000374840.8 | c.472+8delG | splice_region_variant, intron_variant | Intron 5 of 11 | 1 | NM_000478.6 | ENSP00000363973.3 |
Frequencies
GnomAD3 genomes AF: 0.139 AC: 21079AN: 152012Hom.: 1634 Cov.: 29 show subpopulations
GnomAD2 exomes AF: 0.128 AC: 31336AN: 245186 AF XY: 0.130 show subpopulations
GnomAD4 exome AF: 0.154 AC: 224548AN: 1455060Hom.: 19008 Cov.: 32 AF XY: 0.153 AC XY: 110669AN XY: 722962 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.139 AC: 21081AN: 152130Hom.: 1634 Cov.: 29 AF XY: 0.135 AC XY: 10046AN XY: 74362 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:5
Variant summary: The ALPL c.472+12delG variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a benign outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in 15185/113438 control chromosomes (1198 homozygotes) at a frequency of 0.1338617, which is approximately 38 times the estimated maximal expected allele frequency of a pathogenic ALPL variant (0.0035355), suggesting this variant is likely a benign polymorphism. In addition, one clinical diagnostic laboratory classified this variant as likely benign. Taken together, this variant is classified as benign.
Hypophosphatasia Benign:4
This intronic variant is present in GnomAD 4.1 (15.3% (20642 homozygotes)). REVEL score is not applicable. Splice-prediction algorithms predict no effect on splicing. This variant has been reported in the literature in individuals affected with ALPL-related conditions (PMID 34935951, 34097127, 12357339 and 27777120). The applied ACMG criteria can be viewed at: https://alplmutationdatabase.jku.at/table/
ALPL c.472+12del is an intronic variant located in intron 5. This variant is present at high allele frequency in population databases. In conclusion, we classify ALPL c.472+12del as a benign variant.
not specified Benign:3
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at